• 제목/요약/키워드: Non-steroidal Anti-inflammatory Drug

검색결과 69건 처리시간 0.019초

급성염증유발 동물모델에서 포공영(蒲公英)의 염증억제 효과 (Anti-inflammatory Activity of Dandelion in Mice)

  • 함대현;서봉준;한동오;박재현;정은택;이혜정;고윤정;최희돈
    • 동의생리병리학회지
    • /
    • 제22권4호
    • /
    • pp.810-814
    • /
    • 2008
  • Most inflammatory disorders are usually treated using anti-inflammatory drugs including non-steroidal anti-inflammatory drugs (NSAID) and steroidal anti-inflammatory drugs (SAID). Prolonged uses of NSAIDs and SAIDs may frequently cause adverse side-effects such as nausea, vomiting, diarrhea, constipation, decreased appetite, kidney and liver failure, ulcers, and prolonged bleeding after an injury or surgery. Thus, it is necessarily required to develop a new anti-inflammatory drug with little side-effects. Dandelion (Taraxacum officinale) possesses the therapeutic abilities to eliminate body heat and toxins and to remove swelling and inflammation. In order to verify the anti-inflammatory activity of dandelion, TPA(12-O-tetra decanoylphorbol-acetate)-induced or croton oil-induced acute edema was developed in the mouse ears, and dandelion extract dissolved in acetone was applied to both sides of inflamed ears. It was found that dandelion could significantly reduce the ear swelling, compared to that of non-treated control. In the case of $20{\mu}{\ell}$ application of $100mg/m{\ell}$ dandelion solution (DA-100), its anti-inflammatory effect was comparable to that of indomethacin, a non - steroidal anti-anflammatory drug. Taken together, it could be concluded that topically applied dandelion extract exhibited its potentials as a new drug candidate with an effective anti-inflammatory activity.

비스테로이드 소염제의 최신 사용 지침 (Current Guidelines for Non-Steroidal Anti-Inflammatory Drugs)

  • 박민규;유재두;이규호
    • 대한정형외과학회지
    • /
    • 제55권1호
    • /
    • pp.9-28
    • /
    • 2020
  • 비스테로이드 소염제(non-steroidal anti-inflammatory drugs, NSAIDs)는 세계적으로 관절염과 같은 만성 통증에 가장 흔히 사용되는 약물이며 성분 및 기전에 따라 다양한 종류가 있다. 장기간 사용 시에는 소화기계 및 심혈관계 합병증 등의 다양한 부작용이 발생할 수 있는 것으로 알려져 있다. 기존의 비선택적 NSAID와 유사한 진통 효과를 지니면서 위장관계 내약성을 보완해줄 수 있는 cyclooxygenase-2 (COX-2) 선택적 NSAID가 많은 기대를 모았으나 2004년 및 2005년도에 심혈관계 안전성에 대한 우려로 rofecoxib과 valdecoxib의 허가가 취하되면서 NSAID 약물의 부작용에 관한 관심은 더욱 증가하고 있다. 따라서 각 약물의 부작용 및 상호작용을 고려하여 필요한 약물을 최소한으로 사용하는 것이 매우 중요하다. 본 논문에서는 NSAID 약물을 복용할 때 발생할 수 있는 부작용 및 각 약물의 특성을 숙지하며 비선택적 NSAID 및 COX-2 선택적 NSAID의 사용과 관련된 최근 연구 및 지침에 대해 알아보고자 한다.

급성염증 동물모델에서 연옥분과 연옥수의 염증억제 효과 (In Vivo Studies on Anti-inflammatory Activity of Nephrite)

  • 한동오;최보희;이혜정;심인섭;강성길;함대현
    • 동의생리병리학회지
    • /
    • 제19권4호
    • /
    • pp.977-981
    • /
    • 2005
  • Most inflammatory disorders are usually treated using anti-inflammatory drugs including non-steroidal anti-inflammatory drugs (NSAID) and steroidal anti-inflammatory drugs (SAID). In a prolonged use, however, they may frequently produce adverse side-effects. Thus, it is necessarily required to develop a new anti-inflammatory drug with little side-effects. Nephrite has been widely used by traditional oriental medicine to cure the various chronic diseases. In order to verify the anti-inflammatory activity of nephrite, the TPA (12-O-tetradecanoylphorbol-acetate) or the croton oil-induced edema was developed in the mouse ears and the nephrite powder suspension or the nephrite water was directly applied to the ear edema. It was found that nephrite could significantly reduce the ear swelling implying its strong potential as an active anti-inflammatory agent when comparing to indomethacin, a non-steroidal anti-inflammatory drug.

Ketoprofen-Polyethylene Glycol Conjugate: Pharmacokinetics. anti-inflammatory and analgesic activity

  • Jang, Mi-Hee;Kim, Soo-Yeon;Jeong, Choon-Sik;Oh, Seaung-Youl
    • 대한약학회:학술대회논문집
    • /
    • 대한약학회 2002년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2
    • /
    • pp.410.2-411
    • /
    • 2002
  • Ketoprofen (KP), a potent analgesic and non-steroidal anti-inflammatory drug, has some disadvantages such as gastro-intestinal irritation. short half-life (1.5-4 hour) in plasma and low solubility in aqueous solution. In order to minimize these disadvantages. we have recently prepared a KP prodrug, KP-polyethylene glycol conjugate (KPEG750, PEG Mw=750), and investigated its pharmacokinetic behavior. anti-inflammatory and analgesic effect. (omitted)

  • PDF

비스테로이드성 소염진통제 (NSAIDs) 에 의한 것으로 추정되는 담마진성 약진 치험 1례 (A Case of Urticarial Drug Eruption Assumed to be Caused by non-steroidal anti- inflammatory drugs (NSAIDs))

  • 유현정;홍승욱
    • 한방안이비인후피부과학회지
    • /
    • 제20권1호통권32호
    • /
    • pp.256-264
    • /
    • 2007
  • Objective : This study describes a case of urticarial drug eruption assumed to be caused by non-steroidal anti- inflammatory drugs (NSAIDs) treated with oriental medicine and acupuncture. Methods : We studied the case of 20-years-old drug eruption patient. The patient complained of urticaria, angioedema, itching and burning sensation after taking NSAIDs. The indications for NSAIDs prescribed were common cold symptom and sore throat. For diagnosis, blood test and urinalysis were done. For treatment, acupuncture and herbal-medicine treatment were applied. Results : The patient of this report were examined for 13 days. The radiological finding was within normal limits. The WBC, neutrophil, lymphocyte and eosinophil level normalized during admission. After 3 days, itching and wheal reaction of whole body disappeared except facial symptom. The angioedema, itching and wheal reaction in the face was almost improved in the 4th day after discharge. Conclusions : We may expect that the oriental medical therapy improves the urticarial drug eruption caused by NSAIDs.

  • PDF

NSAIDs (Non-Steroidal Anti-Inflammatory Drugs)에 의한 사람 중성구 Cathepsin G의 활성도 억제 (Inhibition of Human Leukocyte Cathepsin G by NSAIDs (Non-Steroidal Anti-Inflammatory Drugs))

  • 배성준;감사열;강구일
    • 대한약리학회지
    • /
    • 제26권1호
    • /
    • pp.51-54
    • /
    • 1990
  • 사람 중성구내의 azurophil granule 내에 존재하는 serine protease인 cathepsin G는 정상 반응에서는 항 박테리아 작용을 나타내는데 관여하지만, 이들의 효소활성이 비정상적으로 증가되었을 때는 오히려 인체 정상 조직을 파괴함으로써 rheumatoid arthritis를 비롯한 여러가지 염증성 질환을 야기시킨다고 알려져 있다. 항염증제로 작용하는데 있어서 prostaglandin 합성을 억제하는 작용 이외에 다른 작용 기전이 있는가 하는것은 대단히 흥미있는 연구 과제이었으므로 neutral protease 중의 하나인 cathepsin G와 이 염증반응에 직접적으로 관여하는지 알아보기 위하여 본 연구에서는 두 단계의 크로마토그라피를 거쳐 순수한 cathepsin G를 분리하고, 여러가지 비스테로이드성 항염증제를 이용하여 cathepsin G에 대한 억제 정도를 관찰하였다. 이중 sulindac, salicylate, phenylbutazone, oxyphenbutazone 그리고 salicyluric acid가 각각 4.3mM, 14.3mM, 6.5mM, 11mM, 15mM의 $IC_{50}$로써 cathepsin G의 활성도를 억제하였다. 따라서 NSAIDs의 항염증 작용 기전은 기존에 알려지고 있는 cyclooxygenase 억제에 따른 prostaglanndin 합성, 분비 억제 기전이외에 rheumatoid arthritis 부위에 직접적 원인으로 작용할 가능성이 있는 cathepsin G를 억제 함으로써 조직 파괴를 막는 역할을 하고 있을 가능성이 있는 것으로 사료된다.

  • PDF

Prasaplai: An essential Thai traditional formulation for primary dysmenorrhea treatment

  • Tangyuenyongwatana, Prasan;Gritsanapan, Wandee
    • 셀메드
    • /
    • 제4권2호
    • /
    • pp.10.1-10.8
    • /
    • 2014
  • Affecting more than half of menstruating women, dysmenorrhea is a cramp which causes abdominal or lower back pain just before or during a menstruation. In western medicine, non-steroidal anti-inflammatory drugs (NSAIDs) are normally used to treat primary dysmenorrheal symptoms. Despite their rapidity in relieving pain, NSAIDs have many serious side effects on the liver, kidney, and gastrointestinal tract. Thai traditional medicines comprise many preparations for treating dysmenorrhea, especially Prasaplai preparation which has been listed in the Thai traditional common household drug list since 2006. The use of Prasaplai was originated about 100 years ago and is still being used in the present time to treat dysmenorrhea. This review focuses on the history of the preparation, active ingredients, and biological activities especially on cyclooxygenase inhibitor, artifacts occurred in the preparation, quantitative analysis, and clinical trial of Prasaplai formulation.

Acute kidney injury caused by administration of zaltoprofen in a cat

  • Baek, Woon-Bum;Kim, Hak-Hyun;Kang, Byeong-Teck;Kang, Ji-Houn;Yang, Mhan-Pyo
    • 대한수의학회지
    • /
    • 제57권1호
    • /
    • pp.55-57
    • /
    • 2017
  • A 5-year-old, 2.7 kg, spayed female Scottish Fold cat presented with hematemesis after administration of oral zaltoprofen, a non-steroidal anti-inflammatory drug, by the owner. Diagnostic imaging and blood analyses indicated development of acute kidney injury (AKI) resulting from zaltoprofen ingestion. To correct dehydration and anemic conditions, the cat received intravenous fluid therapy with whole blood transfusion and peroral N-acetylcysteine. Clinical signs resolved, but persistent azotemia was unresolved indicating that AKI could progress to chronic kidney disease. This case suggests that although zaltoprofen may have low adverse effects on humans, administration of zaltoprofen in cats can have serious adverse effects.

Diclofenac에 의해 유발된 장내세균전위와 지질과산화에 대한 글루타민의 효과 (Effect of Glutamine on the Diclofenac Induced Bacterial Translocation and Lipid Peroxidation)

  • 김은정;김정욱
    • 약학회지
    • /
    • 제49권2호
    • /
    • pp.128-133
    • /
    • 2005
  • The aim of this study was to examine whether administration of glutamine are able to prevent the NSAID induced bacterial translocation and lipid peroxidation in the rats. The an imals with glutamine were fed with L-glutamine for 5 days before diclofenac administration (100 mg/kg orally). 48 hour after diclofenac administration, intestinal permeability, serum biochemical profiles, and malondialdehyde levels of ileum were measured for evaluation of gut damage. Also, enteric aerobic bacterial counts, number of gram-negatives in mesenteric Iymph nodes, liver, spleen and kidney and malondialdehyde levels in liver, spleen, kidney and plasma were measured. Diclofenac caused the gut damage, enteric bacterial overgrowth, increased bacterial translocation and increased lipid peroxidation. Co-administration of glutamine reduced the gut damage, enteric bacterial overgrowth, bacterial translocation and lipid peroxidation induced by diclofenac. This study suggested that glutamine might effectively prevent non-steroidal anti-inflammatory drug induced bacterial translocation and lipid peroxidation in the rat.

울산 지역 소아청소년과 및 이비인후과에서의 항염증제 처방 형태 분석 (Outpatient Prescription Pattern of Anti-inflammatory Drugs by Pediatricians and ENT Physicians in Ulsan City)

  • 김성철;김영록;황재윤;장현욱;남두현
    • 한국임상약학회지
    • /
    • 제20권3호
    • /
    • pp.205-212
    • /
    • 2010
  • The prescription sheets for outpatients from July 2008 to June 2009 from 7 community pharmacies in Ulsan City were surveyed for the anti-inflammatory drug (AID) prescription pattern. The AID prescription rate of pediatricians and ENT physicians were 30.0% and 34.8%, respectively. The oral steroidal anti-inflammatory drugs (SAIDs) were prescribed as much as 3.9% by pediatricians and 10.3% by ENT physicians. The chiefly prescribed oral SAID was prednisolone in pediatric clinics and methylprednisolone in ENT clinics. Meanwhile the prescription rate of oral non-steroidal anti-inflammatory drug (NSAID) was 22.5% by pediatricians and 21.4% in ENT physicians. The most favorable NSAIDs were propionate derivatives in both clinics. In case of externally-applied SAIDs, the prescription rate of pediatricians was 3.6% and that of ENT physicians was 2.8%. Among them, nasal spray, inhalant and gargle formulations for upper respiratory infection (URI) treatment occupied 35.8% of externally-applied SAIDs in pediatric clinics and 59.7% in ENT clinics. Further, it was observed that ENT physicians favored much stronger SAIDs in Group III of ATC classification (75.4% of externally-applied SAIDs) than pediatricians (49.2%). In the survey of AID combination rate, pediatric clinics showed much lower rate (1.4% of total AID prescriptions) than ENT clinics (7.5%). Among them, the combination rate of oral SAID and oral NSAID by ENT physicians (52.2% of total AID combinations) was much higher than pediatricians (36.6%), which might be over-prescription of AID agents. In conclusion, the AID prescription rate as well as AID combination rate, especially in SAID prescriptions, was much higher in ENT than pediatric clinics, which implies the higher confidency on AID drugs of ENT physicians even though the severity of patient's symptom could be considered.